# Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma

> **NCT02993276** · — · COMPLETED · sponsor: **Polyganics BV** · enrollment: 73 (actual)

## Conditions studied

- Neuroma

## Interventions

- **DEVICE:** Neurocap®

## Key facts

- **NCT ID:** NCT02993276
- **Lead sponsor:** Polyganics BV
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-17
- **Primary completion:** 2018-07-06
- **Final completion:** 2020-08-30
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2020-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02993276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02993276, "Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02993276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*